These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 16355013)

  • 1. The key role of insulin resistance in the cardiometabolic syndrome.
    Gill H; Mugo M; Whaley-Connell A; Stump C; Sowers JR
    Am J Med Sci; 2005 Dec; 330(6):290-4. PubMed ID: 16355013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clusterin and Its Role in Insulin Resistance and the Cardiometabolic Syndrome.
    Wittwer J; Bradley D
    Front Immunol; 2021; 12():612496. PubMed ID: 33717095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin and its gene variants as risk factors for insulin resistance, the metabolic syndrome and cardiovascular disease.
    Gable DR; Hurel SJ; Humphries SE
    Atherosclerosis; 2006 Oct; 188(2):231-44. PubMed ID: 16581078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of adiponectin in the development of high fat diet-induced metabolic abnormalities in mice.
    Hecker PA; O'Shea KM; Galvao TF; Brown BH; Stanley WC
    Horm Metab Res; 2011 Feb; 43(2):100-5. PubMed ID: 21165812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overweight and obesity: the pathogenesis of cardiometabolic risk.
    Bray GA; Clearfield MB; Fintel DJ; Nelinson DS
    Clin Cornerstone; 2009; 9(4):30-40; discussion 41-2. PubMed ID: 19789062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of oxidative stress, adiponectin, and nuclear hormone receptors in obesity-associated insulin resistance and cardiovascular risk.
    Matsuda M; Shimomura I
    Horm Mol Biol Clin Investig; 2014 Aug; 19(2):75-88. PubMed ID: 25390017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity--insulin resistance--type 2 diabetes mellitus].
    Małecki MT
    Kardiol Pol; 2006 Oct; 64(10 Suppl 6):S561-6. PubMed ID: 20527377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin resistance-dyslipidemic syndrome: contribution of visceral obesity and therapeutic implications.
    Després JP; Lemieux S; Lamarche B; Prud'homme D; Moorjani S; Brun LD; Gagné C; Lupien PJ
    Int J Obes Relat Metab Disord; 1995 May; 19 Suppl 1():S76-86. PubMed ID: 7550542
    [No Abstract]   [Full Text] [Related]  

  • 11. The importance of treating cardiometabolic risk factors in patients with type 2 diabetes.
    Barnett AH
    Diab Vasc Dis Res; 2008 Mar; 5(1):9-14. PubMed ID: 18398806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different molecular signaling sustaining adiponectin action in breast cancer.
    Panno ML; Naimo GD; Spina E; Andò S; Mauro L
    Curr Opin Pharmacol; 2016 Dec; 31():1-7. PubMed ID: 27552697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Role of Adipocytokines in Type 2 Diabetes as Mediators of Insulin Resistance and Cardiovascular Disease.
    Jaganathan R; Ravindran R; Dhanasekaran S
    Can J Diabetes; 2018 Aug; 42(4):446-456.e1. PubMed ID: 29229313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
    Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
    Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The insulin resistance syndrome: mechanisms of clustering of cardiovascular risk.
    Chan JC; Tong PC; Critchley JA
    Semin Vasc Med; 2002 Feb; 2(1):45-57. PubMed ID: 16222595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players.
    Zimmet P; Boyko EJ; Collier GR; de Courten M
    Ann N Y Acad Sci; 1999 Nov; 892():25-44. PubMed ID: 10842650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent hypoxia in obese Zucker rats: cardiometabolic and inflammatory effects.
    Briançon-Marjollet A; Monneret D; Henri M; Joyeux-Faure M; Totoson P; Cachot S; Faure P; Godin-Ribuot D
    Exp Physiol; 2016 Nov; 101(11):1432-1442. PubMed ID: 27615447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of adiponectin and oxidative stress in obesity-associated metabolic and cardiovascular diseases.
    Matsuda M; Shimomura I
    Rev Endocr Metab Disord; 2014 Mar; 15(1):1-10. PubMed ID: 24026768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adiponectin: a biomarker of obesity-induced insulin resistance in adipose tissue and beyond.
    Lu JY; Huang KC; Chang LC; Huang YS; Chi YC; Su TC; Chen CL; Yang WS
    J Biomed Sci; 2008 Sep; 15(5):565-76. PubMed ID: 18535923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipose tissue, insulin resistance and low-grade inflammation: implications for atherogenesis and the cardiovascular harm of estrogen plus progestogen therapy.
    Tankó LB; Christiansen C
    Climacteric; 2006 Jun; 9(3):169-80. PubMed ID: 16766431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.